058820.KQ

CMG Pharmaceutical Co., Ltd. [058820.KQ] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

058820.KQ Stock Summary

Top 10 Correlated ETFs

058820.KQ

Top 10 Correlated Stocks

058820.KQ

In the News

058820.KQ Financial details

Company Rating
-
Market Cap
300.01B
Income
6.46B
Revenue
93.91B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
265
Optionable
No
Shortable
Yes
Earnings
18 Mar 2021
P/E
0.04
Forward P/E
-
PEG
-0
P/S
0.03
P/B
0.02
P/C
-
P/FCF
0.18
Quick Ratio
1.4
Current Ratio
1.53
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
65
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
75.84%
Revenue Q/Q
-6.61%
EPS Q/Q
-
-
-
-
-
SMA20
-9.48%
SMA50
-23.94%
SMA100
8.25%
Inst Own
-
Inst Trans
-
ROA
15%
ROE
45%
ROC
0.22%
Gross Margin
41%
Oper. Margin
16%
Profit Margin
12%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1993.0-2830.0
52W High
-28.8%
52W Low
+1.1%
RSI
41
Rel Volume
1.43
Avg Volume
368.14K
Volume
526.48K
Perf Week
0.9%
Perf Month
-7.78%
Perf Quarter
3.87%
Perf Half Y
4.84%
-
-
-
-
Beta
0.743
-
-
Volatility
23.61%, 97.12%
Prev Close
1.15%
Price
2015
Change
2.08%

Something similar

Top by Market Cap
CMC.DE
FXAIX
1YD.DE
NVDA
VTI
Top Correlated ETFs
TBX
ZLD.TO
3TYS.MI
PDBA
HEDJ
Top Correlated Stocks
AKA
CPRX
ADN
0685.HK
TKNO
Similar Market Cap
012630.KS
6690.HK
ANG.JO
099190.KQ
JAIBALAJI.NS

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 368.14K
  • Market Capitalization 300.01B
  • Employee 265
  • CEO Joohyung Lee
  • Headquarters Seoul,KR
  • IPO Date 2001-11-19
  • Website https://www.cmgpharma.co.kr

CMG Pharmaceutical Co., Ltd., a pharmaceutical company, develops and sells oral thin film (OTF) pharmaceuticals in South Korea. It offers Tadalafil OTF products for erectile dysfunction; Entecavir OTF products to treat hepatitis type B; Aripiprazole OTF products for schizophrenia; and Montelukast OTF products to treat asthma and allergic rhinitis. CMG Pharmaceutical Co. Ltd. has a strategic collaboration agreement with Handok Inc. for cancer treatment. The company was formerly known as Skynewpharm Co Ltd and changed its name to CMG Pharmaceutical CO., Ltd. in April 2013. CMG Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Seoul, South Korea.